HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Murphy, T. C. Articles by Walter, M. A. Search for Related Content PubMed PubMed Citation Articles by Murphy, T. C. Articles by Walter, M. A.

The Wing 2 Region of the FOXC1 Forkhead Domain Is Necessary for Normal DNA-Binding and Transactivation Functions

¹From the Departments of Ophthalmology and ²Medical Genetics, University of Alberta, Edmonton, Alberta, Canada; ³The New York Eye and Ear Infirmary, New York, New York; ⁴New York Medical College, Valhalla, New York; and the ⁵Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.

PURPOSE. To determine the biochemical defects that underlie Axenfeld-Rieger malformations, to determine a functional role for wing 2 in FOXC1, and to understand how mutations in this region disrupt FOXC1 function.

METHODS. Sequencing DNA from patients with Axenfeld-Rieger malformation resulted in the identification of two novel missense mutations (G165R and R169P) in wing 2 of FOXC1. Site-directed mutagenesis was used to introduce these mutations, as well as previously reported mutation (M161K), into the FOXC1 cDNA. These FOXC1 mutants were evaluated to determine their ability to localize to the nucleus, bind DNA and activate gene expression.

RESULTS. Two novel missense mutations were identified in unrelated patients, in wing 2 of the FOXC1 forkhead domain. Because there had been no previous biochemical analysis, the mutation M161K was also investigated. All three mutant proteins localized correctly to the nucleus. The G165R mutation maintained wild-type levels of DNA binding; however, both the M161K and R169P mutations displayed reduced DNA binding ability. Biochemical analysis showed that all three mutations disrupt FOXC1’s transactivation ability.

CONCLUSIONS. Biochemical analysis of mutations G165R and R169P and of a previously reported mutation, M161K, demonstrate the functional significance of wing 2. M161K and R169P disrupt DNA binding of FOXC1, consistent with the hypothesis that wing 2 is necessary for DNA binding. The results also suggest that wing 2 plays a role in gene activation. These results provide the first insights into how mutations in wing 2 disrupt FOXC1 function.

This article has been cited by other articles:

				S. Chakrabarti, K. Kaur, K. N. Rao, A. K. Mandal, I. Kaur, R. S. Parikh, and R. Thomas The Transcription Factor Gene FOXC1 Exhibits a Limited Role in Primary Congenital Glaucoma Invest. Ophthalmol. Vis. Sci., January 1, 2009; 50(1): 75 - 83. [Abstract] [Full Text] [PDF]

				L. Huang, J. Chi, F. B. Berry, T. K. Footz, M. W. Sharp, and M. A. Walter Human p32 Is a Novel FOXC1-Interacting Protein That Regulates FOXC1 Transcriptional Activity in Ocular Cells Invest. Ophthalmol. Vis. Sci., December 1, 2008; 49(12): 5243 - 5249. [Abstract] [Full Text] [PDF]

				M. H. Strungaru, I. Dinu, and M. A. Walter Genotype-Phenotype Correlations in Axenfeld-Rieger Malformation and Glaucoma Patients with FOXC1 and PITX2 Mutations Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 228 - 237. [Abstract] [Full Text] [PDF]

				Y. A. Ito, T. K. Footz, T. C. Murphy, W. Courtens, and M. A. Walter Analyses of a Novel L130F Missense Mutation in FOXC1 Arch Ophthalmol, January 1, 2007; 125(1): 128 - 135. [Abstract] [Full Text] [PDF]

				N. Weisschuh, P. Dressler, F. Schuettauf, C. Wolf, B. Wissinger, and E. Gramer Novel Mutations of FOXC1 and PITX2 in Patients with Axenfeld-Rieger Malformations. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3846 - 3852. [Abstract] [Full Text] [PDF]

				W. Cella, J. P. Cabral de Vasconcellos, M. Barbosa de Melo, B. Kneipp, F. F. Costa, C. A. Longui, and V. P. Costa Structural Assessment of PITX2, FOXC1, CYP1B1, and GJA1 Genes in Patients with Axenfeld-Rieger Syndrome with Developmental Glaucoma Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1803 - 1809. [Abstract] [Full Text] [PDF]

				F. B. Berry, M. A. Lines, J. M. Oas, T. Footz, D. A. Underhill, P. J. Gage, and M. A. Walter Functional interactions between FOXC1 and PITX2 underlie the sensitivity to FOXC1 gene dose in Axenfeld-Rieger syndrome and anterior segment dysgenesis Hum. Mol. Genet., March 15, 2006; 15(6): 905 - 919. [Abstract] [Full Text] [PDF]

				F. B. Berry, Y. Tamimi, M. V. Carle, O. J. Lehmann, and M. A. Walter The establishment of a predictive mutational model of the forkhead domain through the analyses of FOXC2 missense mutations identified in patients with hereditary lymphedema with distichiasis Hum. Mol. Genet., September 15, 2005; 14(18): 2619 - 2627. [Abstract] [Full Text] [PDF]

				R. A. Saleem, S. Banerjee-Basu, T. C. Murphy, A. Baxevanis, and M. A. Walter Essential structural and functional determinants within the forkhead domain of FOXC1 Nucleic Acids Res., August 6, 2004; 32(14): 4182 - 4193. [Abstract] [Full Text] [PDF]